ElevateBio to Present at the 43rd Annual J.P. Morgan Healthcare Conference ElevateBio will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 10:00 a.m. PST.

ElevateBio Appoints Amy Pooler, Ph.D., as Senior Vice President, Research and Development ElevateBio Appoints Amy Pooler, Ph.D., as Life Edit’s Senior Vice President, Research and Development

ElevateBio Announces Advancements of its Proprietary Lipid Nanoparticle (LNP) Delivery Platform with Liver Targeting and De-Targeting Potential ElevateBio Announces Advancements of its Proprietary Lipid Nanoparticle (LNP) Delivery Platform with Liver Targeting and De-Targeting Potential

ElevateBio Announces New U.S. Patents for Lead Life Edit CRISPR Systems and Adenine Deaminases Enabling Advanced Gene Editing Techniques -  Issued patents provide protection for multiple of Life Edit’s lead adenine deaminases, base editors, and RNA-guided nucleases with applications in base editing and reverse transcriptase editing - ...